Author

Rachel Varley

NO ASSOCIATION BETWEEN POST-INFLAMMATORY PSEUDOPOLYPS AND COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
NO ASSOCIATION BETWEEN POST-INFLAMMATORY PSEUDOPOLYPS AND COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Rachel Varley  et al.

REAL-WORLD EFFECTIVENESS AND SAFETY OF COMBINATION BIOLOGICS AND SMALL MOLECULE THERAPY IN INFLAMMATORY BOWEL DISEASE – A MULTICENTRE STUDY
REAL-WORLD EFFECTIVENESS AND SAFETY OF COMBINATION BIOLOGICS AND SMALL MOLECULE THERAPY IN INFLAMMATORY BOWEL DISEASE – A MULTICENTRE STUDY

Rachel Varley  et al.

ANTI-DRUG ANTIBODIES DETECTED IN THE PRESENCE OF ADEQUATE INFLIXIMAB DRUG LEVELS IN IBD PATIENTS IN CLINICAL REMISSION HAVE LIMITED CLINICAL SIGNIFICANCE
ANTI-DRUG ANTIBODIES DETECTED IN THE PRESENCE OF ADEQUATE INFLIXIMAB DRUG LEVELS IN IBD PATIENTS IN CLINICAL REMISSION HAVE LIMITED CLINICAL SIGNIFICANCE

Rachel Varley  et al.

COST EFFECTIVENESS OF A PROACTIVE THERAPEUTIC DRUG MONITORING STRATEGY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING INFLIXIMAB
COST EFFECTIVENESS OF A PROACTIVE THERAPEUTIC DRUG MONITORING STRATEGY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING INFLIXIMAB

Rachel Varley  et al.

SUBCUTANEOUS INFLIXIMAB – A REAL WORLD EXPERIENCE
SUBCUTANEOUS INFLIXIMAB – A REAL WORLD EXPERIENCE

Rachel Varley  et al.

Item 1 - 5 / 5
1